.After antibody-drug conjugate (ADC) specialist Seagen was actually offered to Pfizer in 2015 for an...
.On the heels of a phase 3 win that neglected to thrill financiers, Ironwood Pharmaceuticals is back...
.Do not stop Monte Rosa Therapies now. The Boston-based biotech is having a ball after signing a cop...
.Welcome to this week's Chutes & Ladders, our summary of notable management hirings, shootings an...
.Celebrating his business's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the posit...
.AbbVie has gone back to the source of its own antipsychotic giant Vraylar seeking one more hit, pay...
.GenSight Biologics is actually full weeks away from running out of amount of money. Again. The biot...
.Monopar Rehabs is actually bouncing back a drug coming from the scrap heap of AstraZeneca's uncommo...
.With brand new data out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of professiona...
.After forming a gene therapy alliance with Dyno Therapeutics in 2020, Roche is actually back for ev...